Report cover image

Oral Hypoglycemic Agents Global Market Report 2025

Published Jul 01, 2025
Length 175 Pages
SKU # BRC20148793

Description

Oral Hypoglycemic Agents Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oral hypoglycemic agents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for oral hypoglycemic agents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oral hypoglycemic agents market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Product Type: Sulfonylureas; Metformin; Thiazolidinediones; Alpha-Glucosidase Inhibitors; Immunotherapy

2) By Administration Route: Oral Tablets; Oral Liquids; Extended-Release Formulations; Combination Therapy Formulations

3) By Patient Type: Type 2 Diabetes Mellitus Patients; Pre-diabetic Patients; Obese Or Overweight Patients; Patients with Multiple Comorbidities

4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Nursing Homes and Long-Term Care Facilities

5) By End users: Hospitals; Clinics

Subsegments:

1) By Sulfonylureas: Glipizide; Glyburide; Glimepiride; Chlorpropamide; Tolbutamide

2) By Metformin: Immediate-Release Metformin; Extended-Release Metformin (XR); Combination Metformin

3) By Thiazolidinediones (TZDs): Pioglitazone; Rosiglitazone

4) By Alpha-Glucosidase Inhibitors: Acarbose; Miglitol; Voglibose

5) By Immunotherapy: Teplizumab; Alum-Formulated GAD (GAD-Alum); Diamyd; Anti-CD3 Monoclonal Antibodies

Companies Mentioned: Pfizer Inc.; Janssen Global Services LLC; Merck Sharp & Dohme Corp.; Bayer AG; Bristol-Myers Squibb Company

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

175 Pages
1. Executive Summary
2. Oral Hypoglycemic Agents Market Characteristics
3. Oral Hypoglycemic Agents Market Trends And Strategies
4. Oral Hypoglycemic Agents Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Oral Hypoglycemic Agents Growth Analysis And Strategic Analysis Framework
5.1. Global Oral Hypoglycemic Agents PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Oral Hypoglycemic Agents Market Growth Rate Analysis
5.4. Global Oral Hypoglycemic Agents Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Oral Hypoglycemic Agents Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Oral Hypoglycemic Agents Total Addressable Market (TAM)
6. Oral Hypoglycemic Agents Market Segmentation
6.1. Global Oral Hypoglycemic Agents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sulfonylureas
Metformin
Thiazolidinediones
Alpha-Glucosidase Inhibitors
Immunotherapy
6.2. Global Oral Hypoglycemic Agents Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Tablets
Oral Liquids
Extended-Release Formulations
Combination Therapy Formulations
6.3. Global Oral Hypoglycemic Agents Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Type 2 Diabetes Mellitus Patients
Pre-Diabetic Patients
Obese Or Overweight Patients
Patients With Multiple Comorbidities
6.4. Global Oral Hypoglycemic Agents Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Nursing Homes and Long-Term Care Facilities
6.5. Global Oral Hypoglycemic Agents Market, Segmentation By End users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
6.6. Global Oral Hypoglycemic Agents Market, Sub-Segmentation Of Sulfonylureas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Glipizide
Glyburide
Glimepiride
Chlorpropamide
Tolbutamide
6.7. Global Oral Hypoglycemic Agents Market, Sub-Segmentation Of Metformin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immediate-Release Metformin
Extended-Release Metformin (XR)
Combination Metformin
6.8. Global Oral Hypoglycemic Agents Market, Sub-Segmentation Of Thiazolidinediones (TZDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pioglitazone
Rosiglitazone
6.9. Global Oral Hypoglycemic Agents Market, Sub-Segmentation Of Alpha-Glucosidase Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acarbose
Miglitol
Voglibose
6.10. Global Oral Hypoglycemic Agents Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Teplizumab
Alum-Formulated GAD (GAD-Alum)
Diamyd
Anti-CD3 Monoclonal Antibodies
7. Oral Hypoglycemic Agents Market Regional And Country Analysis
7.1. Global Oral Hypoglycemic Agents Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Oral Hypoglycemic Agents Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Oral Hypoglycemic Agents Market
8.1. Asia-Pacific Oral Hypoglycemic Agents Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Oral Hypoglycemic Agents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Oral Hypoglycemic Agents Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Oral Hypoglycemic Agents Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Oral Hypoglycemic Agents Market
9.1. China Oral Hypoglycemic Agents Market Overview
9.2. China Oral Hypoglycemic Agents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Oral Hypoglycemic Agents Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Oral Hypoglycemic Agents Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Oral Hypoglycemic Agents Market
10.1. India Oral Hypoglycemic Agents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Oral Hypoglycemic Agents Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Oral Hypoglycemic Agents Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Oral Hypoglycemic Agents Market
11.1. Japan Oral Hypoglycemic Agents Market Overview
11.2. Japan Oral Hypoglycemic Agents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Oral Hypoglycemic Agents Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Oral Hypoglycemic Agents Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Oral Hypoglycemic Agents Market
12.1. Australia Oral Hypoglycemic Agents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Oral Hypoglycemic Agents Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Oral Hypoglycemic Agents Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Oral Hypoglycemic Agents Market
13.1. Indonesia Oral Hypoglycemic Agents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Oral Hypoglycemic Agents Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Oral Hypoglycemic Agents Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Oral Hypoglycemic Agents Market
14.1. South Korea Oral Hypoglycemic Agents Market Overview
14.2. South Korea Oral Hypoglycemic Agents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Oral Hypoglycemic Agents Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Oral Hypoglycemic Agents Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Oral Hypoglycemic Agents Market
15.1. Western Europe Oral Hypoglycemic Agents Market Overview
15.2. Western Europe Oral Hypoglycemic Agents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Oral Hypoglycemic Agents Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Oral Hypoglycemic Agents Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Oral Hypoglycemic Agents Market
16.1. UK Oral Hypoglycemic Agents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Oral Hypoglycemic Agents Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Oral Hypoglycemic Agents Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Oral Hypoglycemic Agents Market
17.1. Germany Oral Hypoglycemic Agents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Oral Hypoglycemic Agents Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Oral Hypoglycemic Agents Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Oral Hypoglycemic Agents Market
18.1. France Oral Hypoglycemic Agents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Oral Hypoglycemic Agents Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Oral Hypoglycemic Agents Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Oral Hypoglycemic Agents Market
19.1. Italy Oral Hypoglycemic Agents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Oral Hypoglycemic Agents Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Oral Hypoglycemic Agents Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Oral Hypoglycemic Agents Market
20.1. Spain Oral Hypoglycemic Agents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Oral Hypoglycemic Agents Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Oral Hypoglycemic Agents Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Oral Hypoglycemic Agents Market
21.1. Eastern Europe Oral Hypoglycemic Agents Market Overview
21.2. Eastern Europe Oral Hypoglycemic Agents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Oral Hypoglycemic Agents Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Oral Hypoglycemic Agents Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Oral Hypoglycemic Agents Market
22.1. Russia Oral Hypoglycemic Agents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Oral Hypoglycemic Agents Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Oral Hypoglycemic Agents Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Oral Hypoglycemic Agents Market
23.1. North America Oral Hypoglycemic Agents Market Overview
23.2. North America Oral Hypoglycemic Agents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Oral Hypoglycemic Agents Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Oral Hypoglycemic Agents Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Oral Hypoglycemic Agents Market
24.1. USA Oral Hypoglycemic Agents Market Overview
24.2. USA Oral Hypoglycemic Agents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Oral Hypoglycemic Agents Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Oral Hypoglycemic Agents Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Oral Hypoglycemic Agents Market
25.1. Canada Oral Hypoglycemic Agents Market Overview
25.2. Canada Oral Hypoglycemic Agents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Oral Hypoglycemic Agents Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Oral Hypoglycemic Agents Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Oral Hypoglycemic Agents Market
26.1. South America Oral Hypoglycemic Agents Market Overview
26.2. South America Oral Hypoglycemic Agents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Oral Hypoglycemic Agents Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Oral Hypoglycemic Agents Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Oral Hypoglycemic Agents Market
27.1. Brazil Oral Hypoglycemic Agents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Oral Hypoglycemic Agents Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Oral Hypoglycemic Agents Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Oral Hypoglycemic Agents Market
28.1. Middle East Oral Hypoglycemic Agents Market Overview
28.2. Middle East Oral Hypoglycemic Agents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Oral Hypoglycemic Agents Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Oral Hypoglycemic Agents Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Oral Hypoglycemic Agents Market
29.1. Africa Oral Hypoglycemic Agents Market Overview
29.2. Africa Oral Hypoglycemic Agents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Oral Hypoglycemic Agents Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Oral Hypoglycemic Agents Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Oral Hypoglycemic Agents Market Competitive Landscape And Company Profiles
30.1. Oral Hypoglycemic Agents Market Competitive Landscape
30.2. Oral Hypoglycemic Agents Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Janssen Global Services LLC Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Merck Sharp & Dohme Corp. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
31. Oral Hypoglycemic Agents Market Other Major And Innovative Companies
31.1. Sanofi S.A.
31.2. AstraZeneca plc
31.3. Novartis AG
31.4. GSK plc
31.5. Takeda Pharmaceuticals Limited
31.6. Eli Lilly and Company
31.7. Boehringer Ingelheim Ltd.
31.8. Novo Nordisk A/S
31.9. Astellas Pharma Inc.
31.10. Laboratoires Servier
31.11. Huadong Medicine Co. Ltd.
31.12. Tonghua Dongbao Pharmaceutical Co. Ltd.
31.13. Gan & Lee Pharmaceuticals Co. Ltd.
31.14. Biocon Limited
31.15. Wanbang Biopharmaceuticals Co. Ltd.
32. Global Oral Hypoglycemic Agents Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Oral Hypoglycemic Agents Market
34. Recent Developments In The Oral Hypoglycemic Agents Market
35. Oral Hypoglycemic Agents Market High Potential Countries, Segments and Strategies
35.1 Oral Hypoglycemic Agents Market In 2029 - Countries Offering Most New Opportunities
35.2 Oral Hypoglycemic Agents Market In 2029 - Segments Offering Most New Opportunities
35.3 Oral Hypoglycemic Agents Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.